Food as medicine: can nutrition boost TB treatment success?
NCT ID NCT06084715
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether providing nutritional support to people being treated for tuberculosis (TB) improves their outcomes. Researchers compared TB patients in Benin, who receive food baskets and meals, to similar patients in Togo, who do not get systematic nutritional support. The goal was to see if nutrition reduces treatment failure, death, or relapse. The study used existing data from national TB programs and included 769 participants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nutritional support
- What this could lead to
- If successful, this study could show that providing food to TB patients improves treatment success and reduces deaths or relapses.
- What could go wrong
- This is an observational study, not a controlled trial, so differences between countries (not just nutrition) could affect results. It cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
769 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
1050 participants will be enrolled and followed for approximately 12 months. 700 will be enrolled in Benin and 350 in Togo. Participants enrolled in Benin will receive nutritional support from the hospital while those enrolled in Togo will not.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Drug susceptible, Xpert \[polymerase chain reaction (PCR) test for TB\] positive and/or sputum stain positive for AFB (≥1+) * Willing to attend follow-up visits and undergo study procedures Exclusion Criteria: * Drug resistant TB * Has received 7 or more days of antimicrobial therapy * Based on study staff observation, the participant is too sick to enroll. Defined as a score of 4 on the World Health Organization (WHO) Performance assessment. * Pregnancy at the time of enrollment * Individuals who are unable to participate in the 6-minute walk test due to pre-existing mobility issues due to disability, trauma, neurological compromise, or cardiopulmonary issues
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Tuberculosis, pulmonary are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier et Universitaire de Pneumo-phtisiologie
Porto-Novo, Benin
-
National Tuberculosis Programme
Lomé, Togo
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 4-Month drug cocktail cure TB as well as 6 months?
- Can a 4-Drug combo cut TB treatment time in half?
- One diet plan to fight two forms of malnutrition in kids?
- Can new drug cocktails shorten TB treatment?
- Soothing sounds: a simple audio may help Low-Birth-Weight babies thrive
- Can higher doses of TB drugs cut treatment time?